Cybersecurity Enterprise Only

TwentyTwo

Biosecurity intelligence for evaluating and safeguarding AI-enabled life sciences

Visit official website
PricingEnterprise Only
Starting priceContact sales
Free planNo
Free trialYes
APIUnknown
Open sourceNo
DeploymentCustom Research Engagement
Last verifiedJuly 30, 2026
Overview

Tool overview

TwentyTwo is listed under Cybersecurity AI tools.

Summary

What is TwentyTwo?

TwentyTwo built AI infrastructure for biosecurity, helping labs, biotechnology companies, governments, and model developers evaluate biological AI capabilities, interpret sensitive outputs, forecast risk, and apply safeguards. The company was acquired by LatchBio and now contributes to Latch Biosecurity.

Best fit

Best for

Life-science and AI organizations evaluating biological model risk and safeguards

Audience

Who is it for?

AI model labsBiotechnology companiesBiosecurity teamsGovernment and policy groupsLife-science platforms
Recommendation

Decision note

This row records a confirmed acquisition without changing the tool name or slug. Before any future rename to Latch Biosecurity, the admin must approve the official-name, website, slug, and permanent-redirect plan while preserving the existing Post ID.

Capabilities

Key features

Biological AI capability research

Model behavior and output interpretation

Safeguard and access-control research

Biosecurity forecasting and evaluation

Integration into the Latch Biosecurity division

Workflows

Use cases

Evaluate biological model capabilities

Assess dual-use research risk

Design safeguards for AI-enabled biology

Forecast emerging biosecurity threats

Support responsible life-science AI deployment

Strengths

Pros

  • Focused on a high-consequence AI safety domain
  • Team combines biosecurity and technical expertise
  • Works across multiple biological model families
  • Acquisition provides a larger life-science platform
Considerations

Cons

  • Standalone TwentyTwo commercial offering is no longer clear
  • Biosecurity conclusions require expert and policy review
Considerations

Limitations

Biosecurity evaluation is inherently uncertain and dual use. Assessments should not replace institutional biosafety, legal, ethics, public-health, model-provider, or government controls. Sensitive details and access must be handled through strict need-to-know procedures.

Cost

Pricing details

Pricing modelEnterprise Only
Starting priceContact sales
Free planNo
Free trialYes
Pricing context

Billing options

Custom research or security engagement

Pricing context

Pricing note

TwentyTwo publishes no standalone self-service price and has been acquired into LatchBio’s biosecurity division. Pricing Model and Starting Price are Contact sales for any current engagement. No ongoing free plan or public self-service trial was confirmed.

View official pricing
Compatibility

Supported languages

  • English
Connectivity

Integrations

LatchBio

Biological model evaluation workflows

Life-science research systems

Specs

Technical details

PlatformsWeb
Multilingual supportNo
Login requiredUnknown
Open sourceNo
DeploymentCustom Research Engagement
CompanyLatchBio
Launch year2025
Models / versionsDNABERT-2 Nucleotide Transformer MoLFormer CodonFM Orthus AlphaGenome ProteinMPNN ESM3 Evo2 AlphaFold3
Editions / plansTwentyTwo research program Latch Biosecurity
Data confidenceHigh
Last verifiedJuly 30, 2026
Decision hub

Finish your evaluation of TwentyTwo

Move between similar tools, comparison cards, quick answers, user reviews, and open discussion without leaving the page.

Tools, comparisons & answers

Explore the best next step before choosing TwentyTwo

Browse similar tools, open focused comparison cards, and answer the most common buying questions.

Answers

Frequently asked questions

TwentyTwo built AI infrastructure for biosecurity, helping labs, biotechnology companies, governments, and model developers evaluate biological AI capabilities, interpret sensitive outputs, forecast risk, and apply safeguards. The company was acquired by LatchBio and now contributes to Latch Biosecurity.
Life-science and AI organizations evaluating biological model risk and safeguards
The listed pricing model for TwentyTwo is Enterprise only. Pricing can change, so users should verify the latest plan details on the official website.
Yes. The current profile indicates that a free trial is available.
Community proof

User reviews

Real user feedback helps others understand strengths, limitations, and the best-fit workflows before choosing this tool.

No reviews Average rating
0 Total reviews
No reviews yet

Be the first to review TwentyTwo

Share what worked, what did not, who this AI tool is best for, and what buyers should verify before choosing it.

Ask in discussion
Tool discussion

Ask or discuss this tool

Ask questions, share workflows, or discuss your experience with this AI tool.

ReplyContinue threads
EditUpdate your posts
ReportKeep it useful
0Total messages
0Threads
0Replies
Start a useful threadAsk, compare workflows, or reply to reviews

Keep it specific and helpful. You can edit or delete your own messages after posting.

Please log in to join the discussion.

Live discussion

Community messages

Reply to messages and keep the discussion useful. Use Report for abuse or spam. Your own posts can be edited or deleted.

No discussion yetBe the first to ask a question or share a useful workflow.